About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Houston | 132 Studies

Clinical Trials SchizophreniaHouston

Schizophrenia Clinical Trials in Houston

Find 132 clinical trials for schizophrenia near Houston, Texas. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-132 of 132 trials

CompletedLurasidone Low-Dose - High-Dose Study StudyThe primary purpose of this study is to evaluate the efficacy of lurasidone 20 mg/day in subjects with an acute exacerbation of schizophrenia.NCT01821378·Little Rock, Arkansas and 65 others

Schizophrenia Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

RecruitingRandomized Withdrawal Study in Patients With SchizophreniaThe purpose of this research is to evaluate the efficacy of dosing iloperidone long-acting injection (LAI) compared to placebo in preventing the exacerbation of symptoms in…NCT06961968·Rogers, Arkansas and 21 others

CompletedA Study of ALKS 3831 in Adults With SchizophreniaThis is a Phase 2, randomized, placebo-controlled multicenter study, which will be conducted in 2 parts.NCT01903837·Little Rock, Arkansas and 60 others

CompletedOlanzapine Versus Active Comparator in the Treatment of Depression in Patients With SchizophreniaThis is a research study comparing the safety and efficacy of two active study medicationsNCT00034801·Tuscaloosa, Alabama and 29 others

CompletedHome-based Transcranial Direct Current Stimulation (tDCS) for Behavioral Symptoms in Alzheimer's Disease and Related Dementias (ADRD)The purpose of this study is to assess acceptability, and safety of providing tDCS to ADRD patients with behavioral symptoms and to assess the efficacy of tDCS for ADRD-related…NCT05478681·Houston, Texas and 1 other

CompletedSmoking Cessation Study for Patients With Schizophrenia or Schizoaffective DisorderStudy will determine whether patients with schizophrenia or schizoaffective disorder can be helped to quit smoking safely while using varenicline and receiving smoking cessation…NCT00644969·Aurora, Colorado and 13 others

CompletedEfficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective DisorderThe purposes of this study are to assess the efficacy, safety, and side effects among doses approved by the Food and Drug Administration and higher (not FDA approved) doses of…NCT00100776·Anaheim, California and 32 others

CompletedPrefrontal Cortical Engagement Through Non-Invasive Brain Stimulation in SchizophreniaCognitive impairments in schizophrenia are the most debilitating aspect of the illness and poorly treated by current medications.NCT02975973·Houston, Texas

CompletedSafety and Efficacy of Cariprazine in SchizophreniaThe objective of this study is to evaluate the efficacy, safety, and tolerability of cariprazine relative to placebo for the treatment of acute exacerbation of schizophrenia.NCT01104779·Costa Mesa, California and 40 others

CompletedLurasidone HCl A Phase 3 Study of Patients With Acute SchizophreniaLurasidone HCl is a compound developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is more efficacious than placebo.NCT00615433·Little Rock, Arkansas and 51 others

CompletedA Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of SchizophreniaThis study is open to people aged 18 years or older with schizophrenia. People can join the study if they are willing to use a smartphone app called CT-155.NCT06791122·Imperial, California and 30 others

CompletedE-cigarettes to Promote Smoking Reduction Among Individuals With SchizophreniaThe purpose of this study is to assess if access to an electronic nicotine delivery device, or e-cigarette, in addition to nicotine patch (21 mg) can help reduce cigarette smoking…NCT02918630·Houston, Texas

PreviousPage 7 of 7

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia